A Phase II Study of SKB264 + SKB118 in Nsq-NSCLC After EGFR-TKI Failure
A Phase II Study of SKB264 + SKB118 in Nsq-NSCLC After EGFR-TKI Failure
Not yet recruiting · NCT07854509 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Study of SKB264 + SKB118 in Nsq-NSCLC After EGFR-TKI Failure | Non-Squamous Non-Small Cell Lung Cancer | Not yet recruiting | Phase 2 | 2026-10-02 | NCT07854509 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 52 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||